Abstract
Scandium radioisotopes are increasingly considered viable radiolabels for targeted molecular imaging (Sc-43, Sc-44) and therapy (Sc-47). Significant technological advances have in-creased the quantity and quality of available radioscandium in the past decade, motivated in part by the chemical similarity of scandium to therapeutic radionuclides like Lu-177. The production and radiochemical isolation techniques applied to scandium radioisotopes are reviewed, focusing on charged particle and electron linac initiated reactions and using calcium and titanium as starting ma-terials.
Cite
CITATION STYLE
Chernysheva, M., Loveless, S. C., Brossard, T., Becker, K., Cingoranelli, S., Aluicio-Sarduy, E., … Engle, J. W. (2021). Accelerator Production of Scandium Radioisotopes: Sc-43, Sc-44, and Sc-47. Current Radiopharmaceuticals, 14(4), 359–373. https://doi.org/10.2174/1874471014999210112205535
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.